MiMedx Group (NASDAQ: MDXG) net income
MiMedx Group reported a net profit of $48.6m for fiscal 2025, 14.5% more than in fiscal 2024 ($42.4m). Its net margin was 11.6%. Earnings per share were $0.33.
MiMedx Group's best year of the last 10 was fiscal 2017. The biggest drop was in fiscal 2024, −27.2%. It reported a loss in 5 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $48.6m | +14.5% | 11.6% | $0.33 |
| 2024 | $42.4m | −27.2% | 12.2% | $0.29 |
| 2023 | $58.2m | — | 18.1% | $0.40 |
| 2022 | −$30.2m | — | −11.3% | −$0.33 |
| 2021 | −$10.3m | — | −4.2% | −$0.15 |
| 2020 | −$49.3m | — | −19.9% | −$0.77 |
| 2019 | −$25.6m | — | −8.5% | −$0.24 |
| 2018 | −$30.0m | −146.3% | −8.3% | −$0.28 |
| 2017 | $64.7m | +16,496.7% | 20.2% | $0.61 |
| 2016 | $0.4m | — | 0.2% | $0.00 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
MiMedx Group net income compared with its sector
By net income for its latest fiscal year, MiMedx Group ranks 134th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of MiMedx Group, 11.6%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 132nd | Emergent Biosolutions | $52.6m | 7.1% |
| 133rd | Repligen | $48.9m | 6.6% |
| 134th | MiMedx Group | $48.6m | 11.6% |
| 135th | Conmed | $47.1m | 3.4% |
| 136th | Envista | $47.0m | 1.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of MiMedx Group
- How much did MiMedx Group earn in fiscal 2025?
- MiMedx Group reported a net profit of $48.6m for fiscal 2025. In fiscal 2024 it reported a net profit of $42.4m.
- What are the earnings per share of MiMedx Group?
- They were $0.33 in fiscal 2025, compared with $0.29 in fiscal 2024.
- What is the net margin of MiMedx Group?
- In fiscal 2025 its net profit was 11.6% of its revenue.
- What was the most profitable year for MiMedx Group?
- Of its last 10 fiscal years, fiscal 2017, with $64.7m.
- Where does MiMedx Group rank in its sector by net income?
- It ranks 134th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for MiMedx Group come from?
- From the annual report (Form 10-K) that MiMedx Group files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that MiMedx Group files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on MiMedx Group: the MiMedx Group page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.